Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Association study of four polymorphisms in the interleukin-7 receptor alpha gene with multiple sclerosis in Eastern Iran.
Internal tremor in Parkinson's disease, multiple sclerosis, and essential tremor.
Oligodendrocyte Regeneration and CNS Remyelination Require TACE/ADAM17.
Comminuted C2 Articular Pillar Fracture in a Patient With Multiple Sclerosis and Recurrent Falls.
Rosuvastatin enhances anti-inflammatory and inhibits pro-inflammatory functions in cultured microglial cells.
Therapeutic efficacy of erythropoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis.
New markers of early cardiovascular risk in multiple sclerosis patients: Oxidized-LDL correlates with clinical staging.
Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies.
The MiRNA Journey from Theory to Practice as a CNS Biomarker.
Laquinimod in the treatment of relapsing remitting multiple sclerosis.
Stop the silent misdiagnosis: patients' preferences matter.
Is Neuromyelitis Optica with Advanced Age of Onset a Paraneoplastic Disorder?
Study of type a and B behavior patterns in patients with multiple sclerosis in an Iranian population.
Therapeutic Decisions in Multiple Sclerosis: Moving Beyond Efficacy.
Baseline Retinal Nerve Fiber Layer Thickness and Macular Volume Quantified by OCT in the North American Phase 3 Fingolimod Trial for Relapsing-Remitting Multiple Sclerosis.
Down-regulation of Myelin Gene Expression in Human Oligodendrocytes by Nitric Oxide: Implications for Demyelination in Multiple Sclerosis.
Body-worn sensors capture variability, but not decline, of gait and balance measures in multiple sclerosis over 18 months.
Interleukin-17 in human inflammatory diseases.
Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of abcd1-deficient mice.
Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis Therapy.
Vitamin D in multiple sclerosis patients: Not the same risk for everybody.
Newer multiple sclerosis drugs and disability scores - are key data analyses missing?
Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis.
Sociocultural and Demographic Risk Factors for the Development of Multiple Sclerosis in Kuwait: A Case - Control Study.
[Towards a nursing consultation in neurosexology].

Pages